MVest Virtual Conference

2022 Virtual Growth Conference

Presented by Maxim Group and M-Vest
March 28 - March 30, 2022

Maxim Group and M-Vest present the 2022 Virtual Growth Conference. This conference will provide a unique opportunity to interact with executives and institutional investors. During this virtual conference, investors will hear from leaders & executives from a wide range of sectors including Biotech, Clean Energy, Electric Vehicles, Financial Services, Fintech & REITS, Gaming & Entertainment, Healthcare, Healthcare IT, Infrastructure, Shipping and Technology / Media / Telecom. Maxim Group and M-Vest will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.

To attend, just sign up to become an M-Vest member and stay tuned for more updates!

B2I DIGITAL, Inc. is a sponsor of the 2022 Virtual Growth Conference presented by Maxim Group and M-Vest. B2I DIGITAL, Inc. is not an affiliate of Maxim Group, LLC or M-Vest (“Maxim”) and is not authorized to represent or act on behalf of Maxim, in any capacity. Maxim has not reviewed and approved the content contained on the b2idigital.com website. No content contained herein shall be considered an offer to solicit the sale of any security.

Learn About Our Featured Companies

Get Informed. Dig into each company's unique story, read their business description, see the bios of senior management and review their documents.

AgriForce Growing Systems Ltd.
(Nasdaq: AGRI)

AgriFORCE Growing Systems Ltd. is an Intellectual Property-driven company focused on the development and acquisition of crop and food production IP and knowledge.

BioCorRx Pharmaceuticals, Inc.
(OTCQB: BICX)

BioCorRx Pharmaceuticals Inc. a developer and provider of innovative treatment programs for substance abuse and related disorders will be presenting.

First Wave Biopharma, Inc.
(Nasdaq: FWBI)

First Wave BioPharma, Inc. is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.